In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Resolve Therapeutics, a US-based healthcare provider, has raised $5.8m in its series B round from a consortium including venture firms New Science Ventures and Easton Capital and WRF Capital, the university venturing unit of Washington Research Foundation. In May 2010, Resolve raised $2m in the initial close of its A round before planning on bringing…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
